bpc-157 drug test Did the FDA Just Approve BPC-157? BPC-157: Experimental Peptide Creates Risk

Its essential for patients to consult with experienced healthcare providers to understand the benefits and risks of lipotropic injections, as well as how they fit into their personal health goals

This is technically true and profoundly misleading

Indeed, there are case reports of monozygotic twins harboring the exact same mutation, both with elevated serum very long chain fatty acids (indicating a similar metabolic defect of peroxisomal lipid processing), where one boy is affected clinically and radiologically, while his twin brother is completely normal (Korenke et al., 1996)

Hartlmller, C., Spreitzer, E., Gbl, C., Falsone, F